Radiomic models distinguish pathology-defined pancreatic cyst risk in surgical cohorts
Source check: Source checked. Not independent scientific confirmation.
Finding: Learned CT-radiomic scores combined with a conventional imaging feature distinguished source-defined benign and malignant pancreatic cyst groups in surgical cohorts. Models developed using 262 patients were evaluated in two 50-patient test sets and a separately recruited 34-patient cohort. The result is retrospective pathology-reference diagnostic evaluation, not evidence that the models improve screening or decisions about surgery.
Technology: LASSO feature selection; multiple learned radiomic classifiers; clinical-radiomic regression
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Learned classifiers map selected CT image features to pathology-defined cyst labels; resulting radiomic scores add information to a clinical imaging-feature model evaluated in separate patient datasets.
- Test and result
- Eleven radiomic classifiers were trained in 262 patients, assessed in 50 temporal internal and 50 external cases, and combined with solid-component information. A34-patient prospectively recruited cohort was subsequently analyzed with those models.
- Limitation / still unknown
- All included patients underwent surgery, restricting the disease spectrum and reference availability. Prospective recruitment does not establish that a frozen model was evaluated before outcomes; validation is classified as retrospective. Full preprocessing/feature-selection nesting is not completely specified. The source-defined grouping combines different lesion types/grades and is not a universal management threshold. Separate fluid-omics mechanism claims are outside this record.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12120750/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Exact primary XML front DOI/title/PMCID/date; clinical cohorts, pathology-label definitions, radiomic/statistical model and validation Methods/Results. Raw biological assay protocols and mechanistic omics sections not processed. Same-day primary bibliographic/notice snapshot reused..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.